BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 10885294)

  • 1. [Prognosis of hypertrophic and dilated cardiomyopathy].
    Ikeda H; Imaizumi T
    Nihon Rinsho; 2000 Jan; 58(1):86-92. PubMed ID: 10885294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.
    Grimm W; Maisch B
    Herz; 2002 Dec; 27(8):750-9. PubMed ID: 12574892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical treatment for cardiomyopathies].
    Suwa M
    Nihon Rinsho; 2000 Jan; 58(1):59-63. PubMed ID: 10885289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of hypertrophic cardiomyopathy].
    Cecchi F; Olivotto I
    G Ital Cardiol; 1999 Oct; 29(10):1199-203. PubMed ID: 10546134
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology and current therapy of congestive heart failure due to idiopathic cardiomyopathy].
    Kambayashi M; Kumada T
    Nihon Rinsho; 1993 May; 51(5):1328-32. PubMed ID: 8101239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Countermeasure for severe acute cardiomyopathies].
    Nakano T; Yamakado T
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):235-9. PubMed ID: 8098351
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
    Ostman-Smith I
    Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
    Kadish A; Dyer A; Daubert JP; Quigg R; Estes NA; Anderson KP; Calkins H; Hoch D; Goldberger J; Shalaby A; Sanders WE; Schaechter A; Levine JH;
    N Engl J Med; 2004 May; 350(21):2151-8. PubMed ID: 15152060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy: do sudden death prevention strategies in children differ between Europe and North America?
    Östman-Smith I; Rossano JW; Shaddy RE
    Curr Opin Cardiol; 2013 Mar; 28(2):130-8. PubMed ID: 23348710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy.
    Müller G; Ulmer HE; Hagel KJ; Wolf D
    Pediatr Cardiol; 1995; 16(2):56-60. PubMed ID: 7540289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan.
    Goto D; Kinugawa S; Hamaguchi S; Sakakibara M; Tsuchihashi-Makaya M; Yokota T; Yamada S; Yokoshiki H; Tsutsui H;
    J Cardiol; 2013 Jan; 61(1):65-70. PubMed ID: 23078864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.
    Merlo M; Pivetta A; Pinamonti B; Stolfo D; Zecchin M; Barbati G; Di Lenarda A; Sinagra G
    Eur J Heart Fail; 2014 Mar; 16(3):317-24. PubMed ID: 24464640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy.
    Kantor PF; Abraham JR; Dipchand AI; Benson LN; Redington AN
    J Am Coll Cardiol; 2010 Mar; 55(13):1377-84. PubMed ID: 20338500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heart failure due to dilated cardiomyopathy].
    Hiramitsu S; Miyagishima K; Mori K; Kimura H
    Nihon Rinsho; 2007 May; 65 Suppl 5():421-4. PubMed ID: 17569321
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypertrophic cardiomyopathy].
    Scheffold T; Binner P; Erdmann J; Schunkert H;
    Herz; 2005 Sep; 30(6):550-7. PubMed ID: 16170688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cardiac myopathies with beta blockers. What do we know, where do we go from here?
    Anderson JL
    Postgrad Med; 1988 Feb; Spec No():104-12. PubMed ID: 2894653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Maintenance therapy and various tests during follow-up of cardiomyopathies].
    Ogasawara S; Kimata S
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):231-4. PubMed ID: 8098350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.